7,376.86

+23.13

+0.31%

51,285.73

-237.37

-0.46%

24,579.42

+264.42

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

74,309.55

-1,362.02

-1.80%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

Hansoh Pharmaceutical Group Company Limited (3692.HK)

34.800 -0.380 (-1.08%)

At close: November 6 at 4:08:50 PM GMT+8

Loading Chart for 3692.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

Can Hansoh Pharmaceutical Group (SEHK:3692) Justify Its Value On Cash Flow?

Can Hansoh Pharmaceutical Group (SEHK:3692) Justify Its Value On Cash Flow?

How Investors Are Reacting To Hansoh Pharma Share Price After EU Drug Filing Validation

How Investors Are Reacting To Hansoh Pharma Share Price After EU Drug Filing Validation

Hansoh Pharmaceutical Group Co Ltd's Dividend Analysis

Hansoh Pharmaceutical Group Co Ltd's Dividend Analysis

Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill

Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill

Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

The U.S. Stocks Quietly Winning the Chinese Drug Boom

The U.S. Stocks Quietly Winning the Chinese Drug Boom

Stocktwits Biotech Dealmaker: Gilead And Roche Double Down On Early-Stage Assets Over Full Buyouts This Week

Stocktwits Biotech Dealmaker: Gilead And Roche Double Down On Early-Stage Assets Over Full Buyouts This Week

Sector Update: Healthcare Stocks Gain Late Afternoon

Sector Update: Healthcare Stocks Gain Late Afternoon

Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress

Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress

GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm

GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

Mobilize your Website

View Site in Mobile | Classic

Share by: